Dr. Russell Abbott Reeves, MD, MS

Dr. Reeves practices at Samaritan Medical Center in Watertown, New York, part of MultiCare Health System.

Dr. Reeves' NPI, 1326573775, was assigned on April 24, 2017. Dr. Reeves holds New York license 327901.

Dr. Reeves' primary practice is Samaritan Medical Center, at 830 Washington Street, Watertown, NY 13601 in Jefferson County. The practice phone is (315) 785-4000.

Dr. Reeves' primary practice is Samaritan Medical Center in Watertown, New York, part of MultiCare Health System. Dr. Reeves is also affiliated with Upstate University Hospital. The medical group on file is Samaritan Medical Center. Dmand AI also links Dr. Reeves to 2 more hospitals, 5 medical groups, 1 group practice or clinic and 1 ambulatory surgery center, each named with a free account. Dr. Reeves' employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reeves practices, 6 sites in all. Vendor and product names are available with a free account.

Vascular and interventional radiology is Dr. Reeves' primary specialty in the NPI Registry, under taxonomy code 2085R0204X. Dmand AI has Dr. Reeves' licenses on file in 3 states: New York, California and Pennsylvania.

CMS data shows 811 Medicare services from Dr. Reeves across 33 procedure codes in 2024, for 751 Medicare patients. Medicare paid $29,563 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 751 Medicare patients who saw Dr. Reeves in 2024. The largest group is 65 to 74, with 298 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Reeves' median patient age at 71, with 52% women.

In 2024, Dr. Reeves wrote 40 Medicare Part D claims for 23 patients. 85% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $26 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Reeves for performance year 2024, reported through an alternative payment model (APM). Dr. Reeves accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Reeves as offering telehealth. CMS counts 17 procedures of leg revascularization (restoring blood flow) by Dr. Reeves, more than 76% of the clinicians it reports for that procedure.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 33 papers to Dr. Reeves, published from 2012 to 2024. 2019 was the busiest year, with 7. The most frequent topics are Postoperative Complications, Comorbidity and Frailty. Dr. Reeves has published most often in J Arthroplasty. Dr. Reeves' most frequent co-authors are Harris Scott Slone, MD, Sophia Angelina Traven, MD and Vincent D. Pellegrini, MD.

CMS Open Payments shows 71 general payments to Dr. Reeves from 14 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 53% of the total. Stryker Corporation paid the most, $1,916.